CN1762458A - Hyperlipemia treating medicine and its preparation method - Google Patents
Hyperlipemia treating medicine and its preparation method Download PDFInfo
- Publication number
- CN1762458A CN1762458A CN 200510112652 CN200510112652A CN1762458A CN 1762458 A CN1762458 A CN 1762458A CN 200510112652 CN200510112652 CN 200510112652 CN 200510112652 A CN200510112652 A CN 200510112652A CN 1762458 A CN1762458 A CN 1762458A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- polygoni multiflori
- fructus
- radix polygoni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 201000005577 familial hyperlipidemia Diseases 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 241000208340 Araliaceae Species 0.000 claims description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 22
- 235000008434 ginseng Nutrition 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 17
- 210000000582 semen Anatomy 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 15
- -1 filtration Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000008504 concentrate Nutrition 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 235000020374 simple syrup Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 23
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 21
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 208000009205 Tinnitus Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 6
- 229960001214 clofibrate Drugs 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 231100000886 tinnitus Toxicity 0.000 description 6
- 230000010354 integration Effects 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 208000019116 sleep disease Diseases 0.000 description 5
- 208000035150 Hypercholesterolemia Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000002105 tongue Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000031288 Combined hyperlipidaemia Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000006575 hypertriglyceridemia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 206010058646 Arcus lipoides Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 201000000351 arcus senilis Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101126525A CN100509016C (en) | 2005-10-13 | 2005-10-13 | Hyperlipemia treating medicine and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101126525A CN100509016C (en) | 2005-10-13 | 2005-10-13 | Hyperlipemia treating medicine and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1762458A true CN1762458A (en) | 2006-04-26 |
CN100509016C CN100509016C (en) | 2009-07-08 |
Family
ID=36746917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101126525A Active CN100509016C (en) | 2005-10-13 | 2005-10-13 | Hyperlipemia treating medicine and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100509016C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167904B (en) * | 2007-11-09 | 2010-07-21 | 北京中科雍和医药技术有限公司 | Medicinal composition for treating hyperlipemia and its preparing process |
CN103055129A (en) * | 2013-02-08 | 2013-04-24 | 黄晶晶 | Traditional Chinese medical preparation for treating hyperlipidemia |
CN103566046A (en) * | 2013-11-25 | 2014-02-12 | 楚雄三平裕康商贸有限公司 | Traditional Chinese medicine composition containing maca, traditional Chinese medicine preparation, and preparation method of traditional Chinese medicine preparation |
CN103992929A (en) * | 2014-06-10 | 2014-08-20 | 南京信息工程大学 | Healthy snow chrysanthemum tea wine with blood pressure and blood fat reducing effects and preparation method of healthy snow chrysanthemum tea wine |
CN109620890A (en) * | 2019-02-25 | 2019-04-16 | 黄章贤 | Chinese medicine composition, liquid medicine and the preparation method of promoting circulation of blood diuresis defaecation |
CN116889598A (en) * | 2023-08-30 | 2023-10-17 | 通化万通药业股份有限公司 | Preparation method of Jiangzhiping oral liquid and its products and use |
CN117180340A (en) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
-
2005
- 2005-10-13 CN CNB2005101126525A patent/CN100509016C/en active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167904B (en) * | 2007-11-09 | 2010-07-21 | 北京中科雍和医药技术有限公司 | Medicinal composition for treating hyperlipemia and its preparing process |
CN103055129A (en) * | 2013-02-08 | 2013-04-24 | 黄晶晶 | Traditional Chinese medical preparation for treating hyperlipidemia |
CN103055129B (en) * | 2013-02-08 | 2013-12-18 | 黄晶晶 | Traditional Chinese medicine preparation for treating hyperlipidemia |
CN103566046A (en) * | 2013-11-25 | 2014-02-12 | 楚雄三平裕康商贸有限公司 | Traditional Chinese medicine composition containing maca, traditional Chinese medicine preparation, and preparation method of traditional Chinese medicine preparation |
CN103992929A (en) * | 2014-06-10 | 2014-08-20 | 南京信息工程大学 | Healthy snow chrysanthemum tea wine with blood pressure and blood fat reducing effects and preparation method of healthy snow chrysanthemum tea wine |
CN109620890A (en) * | 2019-02-25 | 2019-04-16 | 黄章贤 | Chinese medicine composition, liquid medicine and the preparation method of promoting circulation of blood diuresis defaecation |
CN116889598A (en) * | 2023-08-30 | 2023-10-17 | 通化万通药业股份有限公司 | Preparation method of Jiangzhiping oral liquid and its products and use |
CN116889598B (en) * | 2023-08-30 | 2024-06-04 | 通化万通药业股份有限公司 | Preparation method of Jiangzhiping oral liquid and its products and use |
CN117180340A (en) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
CN117180340B (en) * | 2023-11-08 | 2024-04-26 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100509016C (en) | 2009-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101091765A (en) | Medicinal comsns-and usage for preventing and treating diabets mellitus | |
CN100509016C (en) | Hyperlipemia treating medicine and preparation method thereof | |
CN1814167A (en) | Health-care for diabetes | |
CN1739695A (en) | Chinese medicine for treating cataract and its prepn | |
CN1159050C (en) | Compound traditional Chinese medicine preparation for treating type 2 diabetes | |
CN1726929A (en) | Compsn. of medication for treating diabetes | |
CN1706281A (en) | Health food with subsidiary function of lowering blood sugar and lowering blood fat and its production process | |
CN1943713A (en) | A Chinese traditional medicinal composition for treating diabetes and its preparation method | |
CN102861201A (en) | Medicine composition for treating diabetes and preparation method thereof | |
CN101347543A (en) | Chinese medicine compound and preparation method thereof | |
CN1686404A (en) | Dangshen astragalus composition for regulating immunity and its preparation method | |
CN102488838A (en) | Traditional Chinese medicine composition used for treating viral myocarditis | |
CN103211996A (en) | Preparation method of traditional Chinese medicine for treating diabetes mellitus | |
CN1259095C (en) | Brain-quieting hypertension-treating medicine, and its preparing method and use | |
CN1286503C (en) | A Chinese medicinal composition with blood sugar and blood lipid reducing effects, and its preparation method | |
CN101264237A (en) | Medicaments assembly for recuperating sub-health and preparation thereof | |
CN1063649C (en) | Red ginseng and hawthorn fruit health-care wine | |
CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
CN1107711A (en) | Hypoglycemic compound capsule | |
CN1973850A (en) | Medicine composition for treating allergic rhinitis and its prepn process | |
CN1650958A (en) | Origin nourishing kidney boosting wine and its preparation method | |
CN104257960A (en) | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and applications of composition | |
CN103230552A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
CN1042597C (en) | Vision-brighting and blood sugar decreasing composition and its produciton | |
CN1256963C (en) | Antifatigue medicine and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TONGHUA WANTONG PHARMACEUTICAL CO. TD. Free format text: FORMER OWNER: PAN SHOUDE Effective date: 20100625 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100625 Address after: 134000 Tonghua City, Jilin Province Wan Road, No. 66 Patentee after: Tonghua Wantong Pharmaceutical Co., Ltd. Address before: 134000 Tonghua City, Jilin Province Wan Road, No. 66 Patentee before: Pan Shoude |
|
ASS | Succession or assignment of patent right |
Owner name: JILIN WANTONG PHARMACEUTICAL GROUP ZHENGZHOU WANTO Free format text: FORMER OWNER: TONGHUA WANTONG PHARMACEUTICAL CO., LTD. Effective date: 20130814 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 134000 TONGHUA, JILIN PROVINCE TO: 450000 ZHENGZHOU, HENAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130814 Address after: 450000, 34, Holly Street, Zhengzhou hi tech Development Zone, Henan, Zhengzhou Patentee after: ZHENGZHOU WANTONG FUSHENG PHARMACY CO., LTD., JILIN WANTONG PHARMACY GROUP CO. Address before: 134000 Tonghua City, Jilin Province Wan Road, No. 66 Patentee before: Tonghua Wantong Pharmaceutical Co., Ltd. |